Evidence map›Paper›PMID 17438292›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis.

Günter Harth, Paul C Zamecnik, David Tabatadze, Katherine Pierson, Marcus A Horwitz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Advances in therapeutic bacterial antisense biotechnology.Applied microbiology and biotechnology · 2018
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Inhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Günter HarthDivision of Infectious Diseases, Department of Medicine, 37-121 Center for Health Sciences, School of Medicine, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095-1688, USA.
Paul C Zamecnik
David Tabatadze
Katherine Pierson
Marcus A Horwitz
Massachusetts General Hospital · USOklahoma State University Center for Health Sciences · USHarvard University · US

Funding

Novel Antimicrobial Agents Against M. tuberculosisR01AI055352 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HORWITZ, MARCUS AARON · 2004 to 2008
$2.0M
Oligonucleotides as Tools for ChemotherapyR01AI060872 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ZAMECNIK, PAUL CHARLES · 2004 to 2006
$1.3M
NIAID NIH HHS AI 055352NIAID NIH HHS AI 060872NIAID NIH HHS R01 AI055352NIAID NIH HHS R01 AI060872
6 · The paper itself

Abstract

We have investigated the efficacy of modifying gene-specific antisense phosphorothioate oligodeoxyribonucleotides (PS-ODNs) by the addition of 5' and 3' hairpin extensions. As a model system, we have targeted the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase protein complex genes encoding three highly related enzymes (antigens 85 A, B, and C). Whereas the addition of a hairpin extension at only one end of the PS-ODNs did not improve their inhibitory capacity, the addition of hairpin extensions at both ends enhanced their capacity to inhibit M. tuberculosis multiplication in comparison with unmodified PS-ODNs. A combination of three 5'-, 3'-hairpin-modified PS-ODNs (HPS-ODNs) targeting each of the three mycolyl transferase transcripts inhibited bacterial growth in broth culture by approximately 1.75 log units (P < 0.0001) and in human THP-1 macrophages by approximately 0.4 log units (P < 0.0001), which to our knowledge has not previously been demonstrated for any PS-ODN; reduced target gene transcription by > or =90%; caused approximately 90% reduction in mycolyl transferase expression; and increased bacterial sensitivity to isoniazid by 8-fold. The growth-inhibitory effect of the HPS-ODNs was gene-specific. Mismatched HPS-ODNs had no growth-inhibitory capacity. This study demonstrates that 5'- and 3'-HPS-ODNs are highly efficacious against M. tuberculosis and supports the further development of antisense technology as a therapeutic modality against tuberculosis.

Indexed as

Nucleic Acid ConformationAcyltransferasesAntigens, BacterialBacterial ProteinsBase SequenceCell Line, TumorCell ProliferationDrug Evaluation, PreclinicalDrug SynergismGene Expression Regulation, BacterialGenes, BacterialHumansIsoniazidMicrobial Sensitivity TestsMolecular Sequence DataMonocytesAcyltransferasesantigen 85A, Mycobacterium tuberculosisantigen 85B, Mycobacterium tuberculosisAntigens, BacterialBacterial ProteinsIsoniazidOligonucleotides, AntisenseRNA, Messenger

Identifiers

PMID17438292
PMCPMC1855390
OpenAlexW2130583246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.